These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2124632)

  • 21. [Antibacterial properties of lincomycin in vitro and its chemotherapeutic activity].
    Shorin VA; Pevzner NS
    Antibiotiki; 1968 Sep; 13(9):810-5. PubMed ID: 4387685
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
    Odenholt I; Cars O
    J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on the activity of Obioactin with acetylspiramycin on mice infected with Toxoplasma gondii.
    Suzuki N; Espinas FM; Sakurai H; Saito A; Sasaki H; Kato G; Manba K; Taniguchi K; Mochizuki K; Osaki H
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Mar; 256(3):367-80. PubMed ID: 6730783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Bacteriological, pharmacokinetic and clinical studies of SY5555 dry syrup in the pediatric field].
    Toyonaga Y; Ishihara T; Tezuka T; Nakamura H
    Jpn J Antibiot; 1995 Jan; 48(1):71-91. PubMed ID: 7699846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clomethacillin. Synthesis and antibacterial properties].
    Rudzit EA; Pleshakov MG; Radkevich TP; Kulikova DA; Avidon VV
    Antibiotiki; 1974 Oct; 19(10):887-90. PubMed ID: 4218940
    [No Abstract]   [Full Text] [Related]  

  • 26. 4'''-N-demethylspiramycin derivatives: synthesis and evaluation of effectiveness against drug-resistant bacteria.
    Sunazuka T; Shudo H; Nagai K; Yoshida K; Yamaguchi Y; Hanaki H; Omura S
    J Antibiot (Tokyo); 2008 Mar; 61(3):175-84. PubMed ID: 18503196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemical modification of spiramycins. IV. Synthesis and in vitro and in vivo activities of 3'',4''-diacylates and 3,3'',4''-triacylates of spriamycin I.
    Sano H; Sunazuka T; Tanaka H; Yamashita K; Okachi R; Omura S
    J Antibiot (Tokyo); 1984 Jul; 37(7):760-72. PubMed ID: 6469870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Studies on the therapeutics of experimental toxoplasmosis. I. Effect of acetylspiramycin and spiramycin on the intracardiac Toxoplasma multiplication in mice infected with Toxoplasma gondii (author's transl)].
    Espinas FM; Odakura Y; Suzuki N; Sasaki H
    Jpn J Antibiot; 1981 Aug; 34(8):1141-7. PubMed ID: 7321193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Experimental study on the effect of acetylspiramycin on the fertilized ova].
    Suzuki S; Kamata K
    Jpn J Antibiot; 1983 Jun; 36(6):1562-8. PubMed ID: 6655800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimation of source infrared spectra profiles of acetylspiramycin active components from troches using kernel independent component analysis.
    Wang G; Ding Q; Sun Y; He L; Sun X
    Spectrochim Acta A Mol Biomol Spectrosc; 2008 Aug; 70(3):571-6. PubMed ID: 17851124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antibacterial effect of rifampicin and its chemotherapeutic properties in experiments on animals].
    Shorin VA; Shapovalova SP; Malkova IV
    Antibiotiki; 1974 Dec; 19(12):1084-8. PubMed ID: 4155605
    [No Abstract]   [Full Text] [Related]  

  • 32. [Production of a new antibiotic, chalcidin, from Micromonospora chalcea culture].
    Gauze GF; Brazhnikova MG; Shorin VA; Maksimova TS; Ol'khovatova OL; Kudinova MK; Vishniakova IA; Pevzner NS; Shapovalova SP
    Antibiotiki; 1970 Jun; 15(6):483-6. PubMed ID: 4394064
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antipneumococcal activity of erythromycin and spiramycin in 2 experimental models in mice].
    Rolin O; Bouanchaud DH
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):742-5. PubMed ID: 3309807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1989). I. Susceptibility distribution].
    Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1995 Sep; 48(9):1131-60. PubMed ID: 7474333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1999)].
    Shimada K; Nakano K; Ohno I; Okada S; Hayashi K; Yokouchi H; Arakawa M; Gejyo F; Igarashi K; Ikemoto H; Mori T; Okada M; Ozaki K; Igari J; Aoki N; Oguri T; Kitamura N; Terai T; Suzuki Y; Inoue H; Nakadate T; Karasawa Y; Ito C; Yoshida T; Nakata K; Nakatani T; Inagawa H; Ando M; Suga M; Sato K; Kudo K; Kobayashi N; Tosaka M; Hasegawa M; Kohno S; Tomono K; Miyazaki Y; Kobayashi H; Kawai S; Takayasu S; Hirakata Y; Matsuda J; Mochida C; Ito A; Sumitomo M; Nasu M; Nagai H; Matsushima T; Niki Y; Hiramatsu K; Nakano T
    Jpn J Antibiot; 2001 Jul; 54(7):331-64. PubMed ID: 11560054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Shimizu Y; Terai T; Inoue H; Nakadate T; Ito C; Yoshida T; Ohno I; Tanno Y; Arakawa M; Igarashi K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Nakata K; Nakatani T; Inagawa H; Kusano N
    Jpn J Antibiot; 1998 Jul; 51(7):437-74. PubMed ID: 9755430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and in vitro antibacterial activity of catechol-spiramycin conjugates.
    Poras H; Kunesch G; Barrière JC; Berthaud N; Andremont A
    J Antibiot (Tokyo); 1998 Aug; 51(8):786-94. PubMed ID: 9766470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Curative activity of spiramycin adipate by parenteral route in experimental septicemia in mice. Comparison with orally administered basic spiramycin].
    Rolin O; Bouveret E; Bouanchaud DH
    Pathol Biol (Paris); 1986 May; 34(5):476-8. PubMed ID: 3534725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1985). I. Susceptibility distribution].
    Kosakai N; Kumamoto Y; Sakai S; Hirose T; Okayama S; Shigeta S; Shiraiwa Y; Yoshida H; Miura Y; Ogata M
    Jpn J Antibiot; 1987 Dec; 40(12):1975-2011. PubMed ID: 3448255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Purification and characterization of phytomitogens isolated from Phaseolus vulgaris bean].
    Chiang LC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 Aug; 15(3):233-44. PubMed ID: 7140439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.